FIELD: biotechnology.
SUBSTANCE: nano-bodies of the invention are used to prepare bispecific and trispecific polypeptides by binding them to one or two nano-bodies against antigens other than human serum albumin.
EFFECT: invention allows preparation of nano-bodies and polypeptides containing them, having improved affinity for human serum albumin.
29 cl, 62 dwg, 47 tbl, 65 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TNF-α BINDING POLYPEPTIDE AND METHOD FOR TREATMENT OF TNF-α RELATED DISEASES | 2017 |
|
RU2794974C2 |
| IMPROVED NANOBODIES AGAINST TUMOUR NECROSIS FACTOR-ALPHA | 2006 |
|
RU2464276C2 |
| IMPROVED TNF-BINDING AGENTS | 2016 |
|
RU2774823C2 |
| IMMUNOGLOBULINS BINDING AGGRECAN | 2018 |
|
RU2771818C2 |
| METHODS OF PURIFYING SINGLE-DOMAIN ANTIGEN-BINDING MOLECULES | 2009 |
|
RU2553214C2 |
| ADAMTS-BINDING IMMUNOGLOBULINS | 2018 |
|
RU2781182C2 |
| TRISPECIFIC IL-17A, IL-17F AND OTHER PROINFLAMMATORY MOLECULES ANTIBODIES | 2016 |
|
RU2680011C2 |
| IMPROVED AMINO ACID SEQUENCES AGAINST IL-6R AND POLYPEPTIDES WHICH CONTAIN THEREOF FOR TREATMENT OF IL-6R ASSOCIATED DISEASES AND DISORDERS | 2010 |
|
RU2539798C2 |
| FORMULATIONS OF SINGLE DOMAIN ANTIGEN BINDING MOLECULES | 2013 |
|
RU2683861C2 |
| NANOBODIEC TM FOR TREATMENT OF AGGREGATION-MEDIATED DISEASES | 2006 |
|
RU2433139C2 |
